FDA Investigator Dawn M Mccabe

Dawn M Mccabe has inspections in 4 countries as of 01 Sep 2023. Dawn M Mccabe has collaborated with a combinined 2105 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
Last Inspection Date:
01 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Switzerland, United States of America, Germany, Japan
A Williams, Aaron F Coleman, Ademola O Daramola, Alex J Wild, Alexander B Anderson, Althea A Williams, Ana Delp Cintron, Ana P Barido, Anabel Veiga, Andrea H Norwood, Angela E Glenn, Ashley A Mutawakkil, Barbara T Carmichael, Bill Tacket, Jr, Brunilda Torres, Catherine J Laufmann, CDR Ileana Barreto Pettit, CDR Sean T Creighton, Chiaochun J Wang, Christopher T Smith, Chyla T Hunter, Cindy Laboy, Clara E Santiago, Clausnitzer, Craig A Garmendia, Dandan Wang, PhD, Daryl D Javellana, David M Wilkinson, Delkis J Caycedo, Dennis R Hock, Dianiris C Ayala, Dionne D Arline, Dipti Kalra, Don A Leeseberg, Douglas G Ng, Dusty F Snoeberg, Dyvette Arline, Earl Echon, Eduardo Carbonell, Edwards, Edwin J Gorney, Emily A Baldwin, Emir Galevi, Esteban Beltran, Fabian Nchaparro Rodriguez, Gabriel E Muniz, Gale E Ryan, German Rivera, Glenn S Quintanilla, Goran Periz, PhD, Haley H Seymour, Harperd, Heather M Bullock, Hugh M Mcclure, II, Hunt, Jacqueline E Manjone, James E Frye, James To Neal, Jason P Aun, Jennifer D Hollstrom, Jennifer L Huntington, Jennifer Lalama, Jennifer M Menendez, Jessica L Pressley, Joanne E King, Jogy George, John B Crowe, John J Bernal, Jose E Melendez, DDC, Jose Perez Soto, Joshua J Silvestri, K Gonzlez, Karen M Rodriguez, Katherine A Bearss, Katherine A Kellogg, Kelly M Byers, Laura E Garcia, Leo J Lagrotte, Libia M Lugo, Linda K Matheny, Lissette Paiz, LT Richard A Lyght, Luz I Collado, Marc Balzarini, Maria V Price, Marinee Flores Marrero, Meredith M Cobb, Michelle J Glembin, Michelle S Dunaway, Miguel A Martinez, Monica J Wilkins, Msdap Gonzlezk, Nicole M Bell, Omayra Nrodriguez Ruiz, Ormond, Rachel A Peters, Ramon H Pabon Aponte, Raymond A Lyn, Jr, Rebecca Rodriguez, Reynolds, Richard K Vogel, Robert D Tollefsen, Ronan F King, Roy R Rinc, Rozelle G Smith, Ruth A Williams, Salvatore N Randazzo, Sarah E Mcmullen, Sherbet L Samuels, Sonia M Monges, Stanley B Eugene, BS, BME, State Agency, Stephanie D Crockett, Steven A Brettler, Susan M Corrales, Susan M Turcovski, Teresa I Navas, Thomas J Arista, Timothy A Tennell, Tina A Desorcy, Victor Spanioli, Youmin Wang

Dawn M Mccabe's Documents

Publish Date Document Type Title
February, 2015 FDA 483 Oculus Surgical, Inc. - Form 483, 2015-02-27
May, 2013 FDA 483 Capillus LLC - Form 483, 2013-05-16
January, 2012 FDA 483 Pharmatech LLC - Form 483, 2012-01-24
August, 2012 EIR Independent IRB, Inc. - EIR, 2012-08-31
January, 2015 FDA 483 Orbis Medical Inc - Form 483, 2015-01-23
March, 2012 FDA 483 Lexington International, LLC - Form 483, 2012-03-21
August, 2009 FDA 483 Dharma Research, Inc. - Form 483, 2009-08-28
July, 2011 FDA 483 Heartware, Inc. - Form 483, 2011-07-20
December, 2013 EIR Actavis Laboratories FL, Inc. - EIR, 2013-12-20
April, 2011 FDA 483 Brava, LLC - Form 483, 2011-04-04
September, 2011 FDA 483 Marina Medical Instruments Inc. - Form 483, 2011-09-01
November, 2014 FDA 483 Capillus LLC - Form 483, 2014-11-07
December, 2013 FDA 483 Actavis Laboratories FL, Inc. - Form 483, 2013-12-20
July, 2014 FDA 483 Response Alvaro J. Ocampo - Form 483R, 2014-07-25
December, 2012 FDA 483 Vycor Medical, Inc. / NovaVision Vision Technology, Inc. - Form 483, 2012-12-05
December, 2009 FDA 483 Aveva Drug Delivery Systems Inc. - Form 483, 2009-12-04
January, 2012 EIR Pharmatech LLC - EIR, 2012-01-24
November, 2014 FDA 483 Response Capillus LLC - Form 483R, 2014-11-26
July, 2014 FDA 483 Alvaro J. Ocampo - Form 483, 2014-07-07
May, 2015 FDA 483 Fujifilm - Form 483, 2015-05-01
April, 2015 FDA 483 FUJIFILM Healthcare Manufacturing Corporation Sano Office - Form 483, 2015-04-22
January, 2014 EIR Cordis US Corp - EIR, 2014-01-30
April, 2015 FDA 483 Fujifilm Optics Co. Ltd. Mito - Form 483, 2015-04-20

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

Talk to sales to access our investigator profiles


Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more